From its initial identification as a major negative regulatory pathway for epithelial cell proliferation, Transforming growth factor-beta (TGFβ1) and its signaling pathway has been identified as a critical regulator of cancer development and progression in humans and in many experimental cancer models in mice [8, 9]. Here, TGFB1 is linked to cancer.